Corvino Sergio, de Divitiis Oreste, Iuliano Adriana, Russo Federico, Corazzelli Giuseppe, Cohen Dana, Di Crescenzo Rosa Maria, Palmiero Carmela, Pontillo Giuseppe, Staibano Stefania, Strianese Diego, Elefante Andrea, Mariniello Giuseppe
Department of Neurosciences and Reproductive and Odontostomatological Sciences, Division of Neurosurgery, School of Medicine, University of Naples "Federico II", 80131 Naples, Italy.
Division of Ophthalmology, School of Medicine, University of Naples "Federico II", 80131 Naples, Italy.
Cancers (Basel). 2024 Sep 27;16(19):3316. doi: 10.3390/cancers16193316.
Biphenotypic sinonasal sarcoma is a rare low-grade tumor arising from the sinonasal tract, featuring locally aggressive biological behavior, with a tendency to invade the orbit and skull base. There are no defined guidelines of treatment; thus, the management varies among different institutions. The aim of the present study is to provide a modular system of surgical approaches according to the lesion pattern of growth from a literature review. A comprehensive and detailed literature review on the PubMed and Embase online electronic databases on biphenotypic sinonasal sarcoma with orbital invasion was conducted. A personal case exhibiting peculiar features was also added. Demographic (patient's sex and age), clinical (presenting symptoms and time to treatment), neuroradiological (anatomical origin and pattern of growth), and treatment (type of treatment, surgical approach, extent of resection, peri- and postoperative complications, and adjuvant therapies) data, as well as clinical outcome, recurrence rates, and overall survival, were analyzed. Thirty-one patients harboring biphenotypic sinonasal sarcoma with orbital invasion were identified. Tumors mainly affected female patients (66.7%) and a middle-aged population (median 55.2 years old). Simultaneous skull base involvement occurred in most cases (80.6%). Surgery was performed in all but one case (97%), as unique treatment (59%) or in association with radio-(23.5%) and/or chemotherapy (5.9%/2.9%), allowing for gross total tumor resection in most cases (66.7%). The endoscopic endonasal approach was the most adopted surgical corridor (51.7%). The local recurrence rate was 19.3%, and only two cases of tumor-related mortality occurred. Surgery is the only curative treatment, with the main goal to restore/improve/arrest progression of clinical manifestations. The endoscopic endonasal route represents the master approach for lesions confined to the midline. Microsurgical transcranial and endoscopic transorbital approaches have a complementary role for addressing the lesion's component with large intracranial extension or affecting the paramedian aspect of the anterior cranial fossa and superior-lateral orbital compartment, respectively. The approach selection should be made case by case according to the tumor pattern of growth.
双表型鼻窦肉瘤是一种罕见的低级别肿瘤,起源于鼻窦,具有局部侵袭性生物学行为,有侵犯眼眶和颅底的倾向。目前尚无明确的治疗指南,因此不同机构的治疗方式各异。本研究的目的是通过文献综述,根据病变的生长模式提供一个模块化的手术入路系统。我们在PubMed和Embase在线电子数据库上对伴有眼眶侵犯的双表型鼻窦肉瘤进行了全面而详细的文献综述。还增加了一个具有特殊特征的个人病例。分析了人口统计学(患者性别和年龄)、临床(临床表现和治疗时间)、神经放射学(解剖起源和生长模式)和治疗(治疗类型、手术入路、切除范围、围手术期和术后并发症以及辅助治疗)数据,以及临床结果、复发率和总生存率。共确定了31例伴有眼眶侵犯的双表型鼻窦肉瘤患者。肿瘤主要累及女性患者(66.7%)和中年人群(中位年龄55.2岁)。大多数病例(80.6%)同时累及颅底。除1例(97%)外,所有病例均接受了手术,手术作为唯一治疗方式(59%)或与放疗(23.5%)和/或化疗(5.9%/2.9%)联合使用,大多数病例(66.7%)实现了肿瘤全切。内镜鼻内入路是最常用的手术通道(51.7%)。局部复发率为19.3%,仅发生2例与肿瘤相关的死亡。手术是唯一的治愈性治疗方法,主要目标是恢复/改善/阻止临床表现的进展。内镜鼻内途径是局限于中线病变的主要入路。显微手术经颅入路和内镜经眶入路分别在处理具有较大颅内延伸的病变成分或累及前颅窝旁正中区域和眶上外侧间隙的病变方面具有互补作用。应根据肿瘤的生长模式逐案选择手术入路。